A gut bacteria test reads the microbes present in a stool sample, and research published in Nature has just changed how scientists think about what those microbes really are. A team led by the University of Vienna showed that a single species of gut bacteria often contains several evolutionarily distinct populations, each adapted to different conditions inside the intestine. Some of those populations were associated with ageing, inflammatory bowel disease, colorectal cancer and type 2 diabetes. The researchers also reported that highly competitive populations can spread between people and across continents within a few decades. In this article you will learn what the study reported, why the difference between a species and a strain matters, and what a stool analysis can realistically tell you today.
Lo que reportó el nuevo estudio
The researchers analysed thousands of bacterial isolates taken from the human gut, together with metagenomic data — the complete genetic material of an entire microbial community — from people in several countries and across different age and health groups.
They used an approach called reverse ecology, which infers how an organism has adapted to its environment from its genome rather than from laboratory experiments. The signal they looked for was a genome-wide selective sweep: one bacterium acquires a useful mutation, outcompetes its close relatives, and its descendants take over. What is left behind is a population whose members are unusually similar to each other and clearly separate from neighbouring populations. Many familiar gut species turned out to split into several of these lineages.
Qué significa esto para ti
Most microbiome reports available today name species. This work suggests that naming the species may simply not be precise enough, because two populations of the same species can behave very differently inside the body. That is one reason microbiome results have been so hard to interpret so far.
Why strains matter more than species
Grouping bacteria by species is convenient, but it mixes together organisms that occupy different niches. The consequence is practical: it becomes difficult to tell which bacteria are genuinely linked to a disease, which are simply along for the ride, and which may be protective.
According to lead author Xiaoqian Annie Yu, taking evolutionary adaptation into account rather than only counting species makes it possible to identify the biologically relevant units of the microbiome far more accurately. Within one species, some populations turn up more often than others in certain diseases — a pattern that disappears when everything is pooled together.
This matters for anyone who has ever wondered what an intestinal result actually means. It is the same logic that already applies elsewhere in the laboratory: our article explains why the faecal calprotectin test measures inflammation rather than a diagnosis, and another one describes la prueba de cultivo de heces, which looks for named organisms instead of a general balance score.
Gut bacteria that travel between people
The second finding is the one that caught most attention. The team found evidence that highly competitive bacterial populations can spread rapidly across large distances, in some cases expanding across continents within only a few decades. Until now, that pattern had mainly been documented among pathogens, not among ordinary gut residents.
Study leader Martin F. Polz concluded that gut bacteria are more dynamic than previously assumed, and that well-adapted strains can spread internationally and settle into new niches. The practical implication is that diet, medication and lifestyle may not be the only forces shaping your microbiome. Transmission between people could matter too.
That does not make the microbiome contagious in the way a stomach bug is. Nobody in this study caught a disease from a housemate. What the data suggest is slower and quieter: over years, the particular versions of common bacteria that you carry may partly reflect the people and places around you.
What a stool test can and cannot tell you today
None of this is available in a clinic yet. The gap between what research can measure and what a laboratory can validate is the single most useful thing to keep in mind before ordering anything. Cleveland Clinic states plainly that clinical healthcare providers generally do not use or recommend consumer gut microbiome testing kits, because we still do not know enough about how gut microbiota affect health to make such a report useful.
| Question you may have | What today’s tests can say |
|---|---|
| Do I have an infection or a parasite? | Yes. Stool culture and parasite testing look for named organisms and are used in routine care. |
| Is my bowel inflamed? | Largely yes. Faecal calprotectin reflects inflammation in the intestine and helps separate inflammatory disease from irritable bowel syndrome. |
| Is there hidden blood in my stool? | Yes. The faecal immunochemical test detects blood you cannot see and underpins colorectal cancer screening programmes. |
| Is my microbiome balanced? | No agreed answer. There is no validated threshold for a healthy microbiome, and commercial reports are not used in routine clinical care. |
| Do my bacteria mean I will develop a disease? | No. Strain-level associations are group-level research findings, not a prediction for one person. |
One further caution is worth knowing before you pay for a panel: results also carry a long memory of your medical history. We cover that in a separate article on the effect of past medications on gut microbiome results.
Avances científicos recientes
The Vienna work sits inside a wider shift. Three recent studies show what strain-level thinking already delivers, and where it stops.
A pooled analysis in Nature Medicine brought together 3,741 stool metagenomes from 18 cohorts of people with colorectal cancer, adenomas or no disease. Using gut metagenomics alone, the authors improved the accuracy of colorectal cancer prediction and identified strain-specific signatures within two common gut bacteria — meaning that sub-groups within a single ordinary species tracked with later-stage disease. What this means for you: the microbiome is being seriously evaluated as a screening target, but this is population-level accuracy, not a home test.
A second cross-cohort analysis examined 8,117 stool metagenomes from ten cohorts of people with type 2 diabetes, prediabetes or normal blood sugar across the United States, Europe, Israel and China. Nineteen species were linked to type 2 diabetes, and — closer to the Vienna finding — the authors identified within-species diversity for strains of 27 species that helped explain why risk differs from one person to the next. What this means for you: two people can host the same species and still carry different versions of it, which is one reason older microbiome studies disagreed with each other.
A 2025 review of microbiome markers in inflammatory bowel disease, colorectal cancer and coeliac disease reaches a measured conclusion: sequencing has revealed both global shifts and candidate biomarkers, but combining several types of data is still needed before diagnosis or treatment can be built on them. What this means for you: these are promising leads, not settled clinical tools.
All of this is early. None of it changes what a laboratory will report to you this year.
Cuándo hablar con un médico
Symptoms are still what should prompt a consultation, not curiosity about your bacteria. Talk to a healthcare professional if you have diarrhoea lasting more than two weeks, blood in your stool, unexplained weight loss, persistent abdominal pain, or a fever alongside digestive symptoms. Anyone in a national screening age group should also take up colorectal cancer screening when it is offered, whatever a microbiome report says.
If a result is already in your hands and you are unsure what it means, our article covers the stool tests that actually help in persistent diarrhoea, y otro explica colorectal cancer symptoms and screening.
Glosario
| Término | Definición |
|---|---|
| Microbiome | The whole community of bacteria, viruses, fungi and other microbes living in a given place, such as the intestine. |
| Metagenómica | Reading the genetic material of an entire microbial community at once, rather than growing organisms one by one. |
| Species | The usual level at which bacteria are named and reported. It can hide meaningful differences inside the group. |
| Strain | A finer subdivision within a species. Two strains share a name but can differ in what they do in the body. |
| Selective sweep | A helpful mutation spreads through a population so successfully that its descendants replace their close relatives. |
| Reverse ecology | Working out how an organism has adapted to its surroundings by studying its genome instead of observing it directly. |
| Biomarcador | A measurable biological signal used to detect a condition, estimate risk or follow how it evolves. |
| Disbiosis | An unbalanced gut microbial community. There is no agreed numerical threshold that defines it. |
| Faecal calprotectin | A protein measured in stool that rises when the intestinal lining is inflamed. |
| Faecal immunochemical test | A stool test using antibodies to detect small amounts of blood that are invisible to the eye. |
Preguntas frecuentes
Can you catch gut bacteria from another person?
Not in the way you catch a cold. The Nature study found that successful bacterial populations can spread between people and across regions over years or decades, which is a slow ecological process rather than an infection. Sharing a home, a diet and an environment plausibly contributes. This does not mean that living with someone gives you their disease risk, and the study did not test that question.
Should I buy a commercial gut microbiome test?
Most clinicians advise against relying on one. There is currently no agreed definition of a healthy or unhealthy microbiome, so a score labelled good or poor has no validated meaning. If you have digestive symptoms, the tests a doctor can order are more useful because each one answers a specific question.
Which stool tests do doctors actually order?
The common ones are stool culture for bacterial infection, ova and parasite examination, faecal calprotectin for intestinal inflammation, and the faecal immunochemical test used in colorectal cancer screening. Fat measurement in stool may be added when malabsorption is suspected.
Will strain-level testing reach clinics soon?
Not immediately. Research teams can already resolve strains in large datasets, but turning that into a validated test with clear thresholds, reproducible results and demonstrated benefit takes years. The authors themselves describe better biomarkers as a future possibility rather than a present one.
Can diet change which bacterial strains I carry?
Diet clearly influences the overall composition of the gut microbiome, and a varied diet rich in fibre supports microbial diversity. Whether it swaps one strain of a species for another is far less established. The reasonable takeaway is that general dietary advice remains sound, while precise strain engineering through food is not currently achievable.
My stool test came back abnormal. What now?
An abnormal result is a starting point, not a conclusion. What matters is which marker is abnormal, by how much, and alongside which symptoms. Bring the report to the doctor who ordered it so the finding can be placed in context and any follow-up decided.
Fuentes
- Yu XA, Strachan CR, Herbold CW, et al. — Genome-wide sweeps create ecological units in the human gut microbiome — Nature, 2026 — nature.com
- University of Vienna — Evolutionary processes shape bacterial populations in the human gut — Press release, 2026 — univie.ac.at
- Piccinno G, et al. — Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer — Nature Medicine, 2025 — consensus.app
- Mei Z, et al. — Strain-Specific Gut Microbial Signatures in Type 2 Diabetes Revealed by a Cross-Cohort Analysis of 8,117 Metagenomes — Nature Medicine, 2024 — consensus.app
- San-Martin MI, et al. — Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease — International Journal of Molecular Sciences, 2025 — consensus.app
- Cleveland Clinic — Gut Microbiome: overview, function and testing — Health Library — my.clevelandclinic.org
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH) — Gastrointestinal Microbiology and Infectious Diseases — niddk.nih.gov
- American Cancer Society — Colorectal Cancer Screening Tests — cancer.org
Lecturas recomendadas
- Examen de huevos y parásitos: cómo funciona y qué significan los resultados
- La prueba de heces en casa reduce las muertes por cáncer de colon en un 43%
- Consistencia de las heces: la escala de Bristol y qué es normal
- Heces grasosas: causas, estudios y qué significa la esteatorrea
- Prueba de Cyclospora en heces: por qué los exámenes de rutina no la detectan
Entiende tus resultados de laboratorio con AI DiagMe
Research on bacterial strains is moving quickly, but the tests you actually receive are still the classic ones: stool culture, faecal calprotectin, parasite examination, and blood counts alongside them. Those reports are full of numbers and abbreviations that rarely come with an explanation. AI DiagMe reads your blood, urine and stool results and explains in plain language what each value means and which ones deserve attention. It helps you understand a report and prepare your questions; it does not make a diagnosis and does not replace your doctor.
Obtén la lectura de tus resultados en minutos
